Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
about
Diabetes and Hypertension: A Comparative Review of Current GuidelinesRenal cell cancer among African Americans: an epidemiologic reviewRenal protective potential of antihypertensive drugs.Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?The economic impact of hypertension.Choices and goals in the treatment of the diabetic hypertensive patient.Age, race, diabetes, blood pressure, and mortality among hemodialysis patients.Incidence and predictors of end stage renal disease among low-income blacks and whitesDesign and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).Rationale for combination therapy in the treatment of hypertension.New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.Risk of death and the economic accessibility at the dialysis therapy for the renal insufficient patients in Lubumbashi city, Democratic Republic of Congo.Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trialRationale for combination therapy as initial treatment for hypertension.Evidence-based guide to slowing the progression of early renal insufficiency.Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).Treating stage 2 hypertension.Achieving blood pressure goals: why aren't we?High perfusion pressure accelerates renal injury in salt-sensitive hypertension.Blood Pressure-Related Outcomes in a Diabetic Population.Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans.Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.Combined aliskiren-amlodipine treatment for hypertension in African Americans: clinical science and management issues.To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus.Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?Effects of calcium antagonists in hypertensive patients with renal dysfunction: a prospective, randomized, parallel trial comparing benidipine and nifedipine.Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease.
P2860
Q26800179-809BE9BD-9166-4800-ACE9-612CD506D0BDQ33870555-E9F39700-8176-4D77-AC13-63DE9D310EA5Q34075168-953F2504-16D5-42C0-AA6D-8F39B6F85DEFQ34076177-31358884-0B6D-4FE3-9098-6C9631EDFB4DQ34209022-1833F41F-0182-4238-95AF-7280470FDF38Q34365043-A01F2210-71EC-4E5D-9F24-525E894A244FQ34457087-98DB6A15-AC1F-46F9-9606-024B09BBF918Q34461191-402F84D0-7E68-4B01-A1B7-FF1C8EFAC48EQ34488558-4DCE1BB5-1951-4B2C-8006-17A76C8951FDQ34849465-4E71043C-06C0-47F5-B2A1-3AB91FAE1E36Q35027300-7341555F-649A-4648-8E0C-B06DD3DA70DDQ35049079-BCF65885-1FC6-49BE-A9BD-CD91C4157397Q35147022-34D786F8-EE4D-4C9A-B429-374DC66DBB11Q35207037-0B928C4E-8EE5-4151-A6AC-8397759BEE5FQ35641499-4DB801E4-7E9C-4576-B515-0BE0EAF2BDB9Q36158003-FFF4E46D-F11E-44F1-9283-856639624722Q36231654-62CFD4E8-200D-4529-B8E9-5CB753A08597Q36684801-71FCF3C9-6491-4378-ABCC-ED42A2330E9AQ36796765-011DADC1-D40D-4E24-9CB4-8F61EE326E0FQ36989451-BE254D34-6C67-4EA4-A071-55594A163FCBQ37235015-E901867C-F8BC-480E-9C22-A5AB8E7F603EQ37315597-27210C6D-F7E8-4E2E-B8E6-5744B0DD66C9Q37878706-15499874-681B-4F20-B3D3-A880F1E33DA6Q38098108-20348750-78F2-4A30-B388-090C9BD6EFB0Q38587653-691F6D19-9F27-465E-8CF3-E7DDE6685BEDQ40184938-64AFE194-EDA4-4451-9DFB-B553187C6786Q43497625-E8BC0E53-9258-4192-9798-0FD1887DA39FQ44452204-E909B314-3B64-43C3-9547-97DFC8E00BB0Q44701637-77DF7E60-C772-4141-A4F7-EBF1CAFCC1FAQ44787249-EF768722-36B1-4577-A336-C3116A047E20Q45123562-03D01DE8-9C88-4D7A-860A-9AD1512296F2Q54706881-5B077B29-F936-4C42-8EA9-A6856713FC2D
P2860
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Effects of blood pressure cont ...... in Renal Disease Study Group.
@en
Effects of blood pressure cont ...... in Renal Disease Study Group.
@nl
type
label
Effects of blood pressure cont ...... in Renal Disease Study Group.
@en
Effects of blood pressure cont ...... in Renal Disease Study Group.
@nl
prefLabel
Effects of blood pressure cont ...... in Renal Disease Study Group.
@en
Effects of blood pressure cont ...... in Renal Disease Study Group.
@nl
P2093
P356
P1433
P1476
Effects of blood pressure cont ...... in Renal Disease Study Group.
@en
P2093
J A Breyer
L A Hebert
L Y Agodoa
P304
P356
10.1161/01.HYP.30.3.428
P407
P433
P577
1997-09-01T00:00:00Z